Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00701051 · ClinicalTrials.gov registry record · NA

Exercise Training and Glucose Metabolism in Aging

A NA study of Type 2 Diabetes Mellitus and Impaired Glucose Tolerance (Prediabetes), sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT00701051: Completed NA study of Type 2 Diabetes Mellitus and Impaired Glucose Tolerance (Prediabetes), sponsored by US Department of Veterans Affairs.

NCT00701051 is a NA study of Type 2 Diabetes Mellitus and Impaired Glucose Tolerance (Prediabetes) that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 90 participants, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00701051, a NA study of Type 2 Diabetes Mellitus and Impaired Glucose Tolerance (Prediabetes), has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in older individuals with impaired glucose tolerance and we hypothesize that this is due to reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize that reversal of a sedentary lifestyle through aerobic exercise training will increase insulin signaling and vascular growth factor expression, as well as decrease inflammation, to increase capillary supply to skeletal muscle, which contributes to improved glucose metabolism in older adults. This study will: 1) Determine the mechanisms underlying reduced skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2) Determine the effect of aerobic exercise training-induced increases in skeletal muscle capillarization on glucose metabolism in older adults.

Primary Outcome

Insulin-stimulated glucose uptake

Interventions

  • BEHAVIORAL Aerobic exercise training
  • BEHAVIORAL Detraining (cessation of exercise)

Study Locations (1)

Maryland

  • VA Maryland Health Care System, Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2006-10
Est. Completion 2012-06
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00701051 record still lists

NCT00701051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Aerobic exercise training is the first listed.

NCT00701051 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00701051 about?

NCT00701051 is a clinical study titled "Exercise Training and Glucose Metabolism in Aging". Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skelet...

What is the current status of trial NCT00701051?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2006-10. Estimated completion is 2012-06.

What conditions does trial NCT00701051 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Impaired Glucose Tolerance (Prediabetes).

What interventions are being tested in trial NCT00701051?

The interventions under investigation include: Aerobic exercise training (BEHAVIORAL), Detraining (cessation of exercise) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00701051?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00701051 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00701051's enrollment target sits among peer trials

90 58th of 130 higher than 72 of 130 other Type 2 Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00701051, the US trial registry maintained by the National Library of Medicine. NCT00701051 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.